NOVAVAX 13.05USD , +0.31 ,+2.43%
Today Novavax is trading on 13.05 USD the Stock keeps on going up because the company announced positive news from the phase 3 trial for its flu vaccine, NanoFlu. The treatment met both the primary and secondary expected results of the experiment and it came out with positive results. These strong Phase 3 results align with and validate their previous clinical trials, in which NanoFlu showed higher HAI antibody responses than the leading flu vaccine for older adults that was there before. It is expected that both Fast Track designation and the accelerated approval pathway from the FDA( which is a US department responsible for protecting the public health by ensuring the safety of humans ) will help Novavax bring NanoFlu to market as quickly as possible to address the serious public health threat of influenza and the virus outbreak.